HOME > Business Wire > Article
Ascender Capital Calls for Improved Capital Allocation Policy at Cresco Ltd (4674)
- Cresco operates a superior, stable business but remains severely undervalued
- Ascender has filed shareholder proposals for the June 2025 AGM
- Ascender also calls for the divestment of the ¥8 billion actively managed investment portfolio
TOKYO--( BUSINESS WIRE )-- Ascender Capital Limited (“Ascender Capital”), a Hong Kong-based investment firm focused on high-quality businesses across Asia, is a long-term investor in the Japanese software and system integration sector, where it has allocated over half of its assets in recent years. The firm actively follows more than 100 publicly listed companies in the space and has met with management teams at over 50 of them since 2015.
Ascender Capital has a strong track record of constructive engagement with companies to enhance long-term corporate value. In line with the objectives of the Japan Stewardship Code and global best practices, we have been engaging with Cresco Ltd. (“Cresco” or “the Company”) management and Board since November 2023, urging improvements in capital allocation and corporate governance.
Ascender Capital is a long-term shareholder of Cresco, currently holding approximately 2.2% of the shares.
Strong Operations Undermined by Poor Capital Allocation
Since 2015, Cresco’s operating margin has increased from 8.0% to 10.2%, driving annual growth in operating income of 12%. Cumulative operating cash flow of ¥28 billion has largely accumulated on the balance sheet.
FY3/2025 was another strong year: revenue rose by 11%, operating income increased by 17%, and FY3/2026 guidance targets a further 17% gain in operating profit.
We commend management for these strong results, reflecting stable client relationships and operational excellence. However, shareholders have seen limited benefit. The ¥26 billion in cash flow generated over the last decade remains idle. Excluding excess capital (defined as anything beyond three months of SG&A), we estimate the Company’s ROE could reach 50% — more than triple the current 15%.
The announced increase in the dividend payout from 40% to 50% and the 2.5% share buyback disclosed on 9 May 2025 are welcome, but only partially address the issue.
Valuation Disconnect
Despite these strong fundamentals, Cresco trades at only 14x P/E — a 26% discount to the System Integrators (SI) sector average of 19x. On an ex-cash/LTI basis, the P/E drops to below 9x.
This discount is not a reflection of business quality. It stems from ineffective capital allocation, overcapitalization, and a governance structure in need of reform.
Shareholder Proposals
Ahead of the upcoming June 2025 AGM, Ascender Capital has submitted the following proposals in the interest of all shareholders:
- Transfer authority to set dividends to the General Meeting of Shareholders — consistent with best practices across 90% of listed companies in Japan
- Increase dividends:
a. Declare a special dividend of ¥46 per share to normalize the cash balance relative to operational needs
b. Distribute a year-end dividend of ¥54 per share for FY3/2025 — resulting in a 75% payout ratio, a sustainable level for Cresco’s asset-light model
- Expand share buybacks to 8.8 million shares (21% of shares outstanding), and immediately cancel all treasury shares
Even after implementing these measures, Cresco would still hold over ¥6 billion in cash — well above operational requirements. Moreover, annual operating cash flows exceeding ¥5 billion will continue to replenish reserves and support strategic initiatives.
Supporting Analysis
Overcapitalization of the Balance Sheet
As of March 2025, Cresco’s net cash and long-term investments amount to over 4 years’ worth of SG&A — far in excess of what is needed to run the business efficiently.
This level of capital is excessive for a company with a 15-year track record of uninterrupted positive cash flow, including through the 2008 Global Financial Crisis, the 2011 Tōhoku Earthquake, and the COVID-19 pandemic.
Cresco has executed a highly successful M&A program over the last decade with just ¥3 billion. Future transactions of similar scale can be easily financed through operating cash flow or modest leverage.
There is no financial justification for maintaining such an overcapitalized balance sheet.
Risky Investment Management
Cresco incurred derivative losses in FY3/2020 and FY3/2023 through active management of a ¥8 billion financial investment portfolio. This speculative activity is inappropriate for a system integrator and detracts from the Company’s core focus in a rapidly consolidating IT services market.
We call on the Company to immediately liquidate these investments and redeploy the capital toward shareholder returns.
Improving Shareholder Engagement
Cresco has no controlling shareholder and should therefore be fully accountable to its public investors. While management has been hospitable and courteous, engagement has lacked depth and substance.
The Board’s superficial rejection of our shareholder proposals — in its 9 May 2025 response — reflects either a fundamental misunderstanding of capital allocation or a disregard for fiduciary responsibility.
Further Information
More details are available in the News section of our website or through these direct links:
-
Shareholder proposals in English Shareholder Proposals – ENG
-
Shareholder proposals in Japanese Shareholder Proposals – JPN
-
Improvement Plan for Cresco – ENG
This press release does not constitute an offer to purchase or sell shares in Cresco Ltd.
About Ascender Capital
Founded in December 2012, Ascender Capital is a Hong Kong-based value orientated investment firm concentrated on opportunities in Asia including Japan. The fund focuses on high-quality companies with a track record of profitability and earnings growth.
DISCLAIMER
Ascender Capital is the investment manager of private funds (the “Ascender Capitals Funds”) that own shares in Cresco. Ascender Capital has created this communication to enable fellow shareholders to carefully monitor how sincerely the board of directors and management of Cresco address our concerns, listen to shareholders’ views and endeavor to increase the value of Cresco shares in the best interest of all shareholders.
Ascender Capital is not and should not be regarded or deemed in any way whatsoever to be (i) soliciting or requesting other shareholders of Cresco to exercise their shareholders’ rights (including, but not limited to, voting rights) jointly or together with Ascender Capital, (ii) making an offer, a solicitation of an offer, or any advice, invitation or inducement to enter into or conclude any transaction or (iii) any advice, invitation or inducement to take or refrain from taking any other course of action (whether on the terms shown therein or otherwise).
Further, this communication and information to be found on its Website do not purport to recommend the purchase or sale of any security nor do they contain an offer to sell or a solicitation of an offer to buy any security. Nothing in this communication or on the Website is intended to be, nor should it be construed or used as, investment, tax or legal advice.
This communication and the Website exclusively represent the opinions, interpretations, and estimates of Ascender Capital in relation to Cresco’ business and governance structure. Ascender Capital is expressing such opinions solely in its capacity as an investment adviser of the Ascender Capital Funds.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250603293349/en/
Contacts
For enquiries please contact:
English release
Jean-Charles Tisserand
Edouard Mercier
info@ascendercapital.com
+852 3758 2608
Japanese release
Ashton Consulting
Tokyo
ascender@ashton.jp
+81 3 5425 7220
Source: Ascender Capital Limited
Business Wire
-
06/05 14:00 Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Pa...
-
06/05 14:00 Chris Cope Joins CADDi as Vice President of Engineering
-
06/05 13:00 Capcom’s New Sci-Fi Action-Adventure Game PRAGMATA to Launch in 2026!
-
06/05 13:00 Lone Star Funds to Acquire Portfolio of Nine Purpose-Built Student Acc...
-
06/05 12:00 Allay Therapeutics Announces $57.5M Series D Financing and Venture Deb...
-
06/05 12:00 Southwest Power Pool (SPP) Partners with Hitachi to Develop Advanced A...
-
06/05 03:30 Eurofins Consumer Product Testing Announces State-of-the-Art Expansion...
-
06/04 23:46 SQUARE ENIX Announces FINAL FANTASY TACTICS - The Ivalice Chronicles ...
-
06/04 23:00 Palliser to Vote Against President Kobayashi and Other Directors at Fo...
-
06/04 23:00 RGA Announces Coinsurance Transaction With Anshin Life
-
06/04 13:00 Capcom’s Monster Hunter Rise: Sunbreak Sales Exceed 10 Million Units!
-
06/04 08:37 STARLUX Airlines and Etihad Airways Launch Codeshare Partnership
-
06/04 05:10 KATE, Japan’s No. 1 Makeup Brand, Launches Strategic Initiatives to ...
-
06/04 03:00 Mitsubishi Electric Invests in AT PARTNERS III L.P. Fund Targeting VCs
-
06/04 03:00 Mitsui Chemicals Group to exhibit at ProPak Asia 2025
-
06/03 23:50 Ascender Capital Calls for Improved Capital Allocation Policy at Cresc...
-
06/03 22:42 Japan Delegation Visits Illinois to Deepen Quantum Innovation Ties
-
06/03 22:00 EdgeCortix’s SAKURA-II AI Accelerator Brings Low-Power Generative AI...
-
06/03 14:12 European Commission Approves ADCETRIS® (brentuximab vedotin) for the ...
-
06/03 13:03 Panasonic Debuts WR-AV800 AV Processor
-
06/03 12:30 Asahi Kasei Receives Imperial Invention Prize in Japan for Nickel-Coat...
-
06/03 07:35 BELFOR Highlights Digital Transformation in Damage Assessment at Asia ...
-
06/03 04:00 Yokogawa Announces Release of Next-Generation of the CENTUM VP Integra...
-
06/03 02:00 Cheese Confectionery Specialty Store “NEWYORK PERFECT CHEESE”: Piz...
-
06/02 23:00 RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ich...
-
06/02 16:00 OKI Establishes OKI Berlin Lab R&D Center in Berlin, Germany
-
06/02 15:15 FIA President Mohammed Ben Sulayem to Visit Japan to Highlight Global ...
-
06/02 14:00 NRI Wins "Best Cutting-Edge Solution" at FTF News Technology Innovatio...
-
06/02 13:00 Fujifilm Rebrands Life Sciences Companies to Strengthen Position as St...
-
06/02 12:55 Guidewire Wins Six XCelent Awards and ‘Luminary’ Distinction in Ce...